Chemical Business Newsbase articles from October 2006

Chemical Business Newsbase archives from October 2006

Bayer forms PU joint venture in United Arab Emirates.
October 31, 2006... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Bayer MaterialScience AG is forming a PU system house joint venture with Pearl Insulation Materials Industries LLC in Dubai. The focus of the venture will be looking after...

Mexican chemical industry expanding strongly.
October 31, 2006... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Mexico's chemical industry grew in 2005. Production was up 7.3% at $15.83 bn. Domestic demand was up 7.2% and investment was up 24.4% at $1.17 bn. Imports of petrochemicals...

Sued-Chemie takes over Tricat Zeolites.
October 31, 2006... (From Chemical Business NewsBase - Chemie Technik (Heidelberg)) Sued-Chemie is taking over Tricat Zeolites with effect from 30 Sep 2006. Tricat produces zeolite catalysts for use in refineries, the petrochemicals industry and the...

Whirlpool shifts work, Moll to close three plants.
October 31, 2006... (From Chemical Business NewsBase - Plastics News) Dallas, TX, USA-based Moll Industries Inc will close three factories in the USA as it ends its moulding business with Benton Harbor, MI, USA-based Whirlpool Corp. Moll will eliminate 416...

Rehau opening extrusion plant in Mexico.
October 31, 2006... (From Chemical Business NewsBase - Plastics News) Leesburg, VA, USA-based Rehau Inc is investing around $4.5 M to boost its operation in Mexico. The expansion, which involves leasing a 28,000 sq ft extrusion and fabrication plant in...

North America slowly adopting new pipe materials.
October 31, 2006... (From Chemical Business NewsBase - Plastics News) New plastic pipe materials are being introduced in North America as the region adopts technology already used in Europe. Cross-linked polyethylene (PEX) pipe is gaining popularity in North...

Orkla results up strongly in 3Q 2006.
October 31, 2006... (From Chemical Business NewsBase - Dagbladet Borsen) In 3Q 2006 Orkla reported a pretax result of DKR 1.3 bn, which was very much in line with analysts' expectations. The turnover of DKR 11.2 bn reflected strong progress by all the...

Expected loss for Genmab in 3Q 2006.
October 31, 2006... (From Chemical Business NewsBase - Dagbladet Borsen) In 3Q 2006 Genmab, Denmark, recorded a loss of DKR 111.7 M after tax, bringing the loss for 1-3Q 2006 to DKR 301.5 M. Such a loss was expected and the company is maintaining its...

Akzo Nobel sells macroporous polymer systems business.
October 31, 2006... (From Chemical Business NewsBase - Chemisch2Weekblad) Akzo Nobel is selling its MPP (macroporous polymers) Systems business unit to Veolia Water and Solutions Technologies. MPP Systems is based at Arnhem and in 2005 reported a turnover of...

Crucell to cut 60 jobs in Bern.
October 31, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) The acquisition of Swiss vaccines manufacturer Berna Biotech by the Dutch company Crucell will lead to the reduction of around 60 jobs in Switzerland, primarily in Bern. Crucell...

Alcan 3Q 2006 profits jump to $456 M: regional.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Metals News) Canada-based Alcan's net income increased to $456 M in 3Q 2006 from $81 M in 3Q 2005, while sales and operating revenues also increased to $5.77 bn from $4.98 bn. The strong...

Copper wire, cable exports total $650 M in Jan-Sep 2006: Brazil.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Metals News) Brazilian non-ferrous metals industry trade group Sindicel noted that export revenues of the local copper wire and cable industry reached $650 M in Jan-Sep 2006. The country...

EOG Jan-Sep 2006 natural gas output up 27%: Trinidad and Tobago.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) US oil company EOG Resources' increased its natural gas production in Trinidad and Tobago by 27.1% to 267 M cu ft/day (7.56 M cu m/day) in Jan-Sep 2006 as against the same...

PDVSA warns clients of output cut: Venezuela.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Venezuelan state oil firm PDVSA is sending a letter to all its foreign clients with regard to its plan to slash production by 138,000 bbls/day starting 1 Nov 2006. The cutback...

Pequiven sees net profits of $372 M in 2006: Brazil, Venezuela.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Venezuela-based Pequiven anticipates recording Bolivares 800 bn ($372 M) in net profits in 2006. The company's profitability is partly attributed to higher natural gas...

In brief: Petropar delays opening ethanol expansion project offer until 3 Nov 2006 - Paraguay.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Paraguay-based Petropar has rescheduled the opening bid for the upgrading of its Mauricio Jose Troche ethanol plant to 3 Nov 2006. The opening bid was originally set on 31 Oct...

Lower oil prices impact Enap nine-month bottom line: Chile.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Chilean state oil company Enap's net profit dropped 43% to $132 M in Jan-Sep 2006 as against the same period in 2005. The decline was attributed to lower international oil...

PDVSA Etanol expects to satisfy local demand by 2009: Venezuela.
October 31, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Venezuela-based PDVSA's ethanol-producing unit, Proyecto Etanol, will commence production of ethanol in 2007. The subsidiary intends to cover the local market by 2009 prior to...

Pharmexa reveals GV1001 results from pancreatic cancer trials.
October 31, 2006... (From Chemical Business NewsBase - Net Posten) Pharmexa has already announced that the telomerase vaccine GV1001 for the treatment of pancreatic cancer had proved safe and immunogenic in Phase I/II clinical trials and has now revealed the...

Handelsbanken disappointed with Novo Nordisk 3Q 2006 results.
October 31, 2006... (From Chemical Business NewsBase - Net Posten) According to Handelsbanken Novo Nordisk's turnover was below expectations for all primary product areas in 3Q 2006. In particular, sales of human insulin fell by 6% relative to 3Q 2005 and...

Importer of controlled substances: notice of application (ISP Freetown Fine Chemicals Inc).
October 31, 2006... (From Chemical Business NewsBase - Federal Register) On 16 Aug 2006, ISP Freetown Fine Chemicals Inc, 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the US Drug Enforcement Administration (DEA) to be...

Importer of controlled substances: notice of application (Cerilliant Corp). [1 table in original article].
October 31, 2006... (From Chemical Business NewsBase - Federal Register) On 19 Jul 2006, Cerilliant Corp, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the US Drug Enforcement Administration (DEA) to be registered as an...

MGI Pharma announces specific J code assignment for Dacogen.
October 31, 2006... (From Chemical Business NewsBase - Press Release) MGI Pharma Inc announced that the Centres for Medicare and Medicaid Services (CMS) have assigned a specific J-code for Dacogen (decitabine) for Injection. Effective 1 Jan 2007, code J0894...

Antitrust authorities approve Siemens' acquisition of Bayer Diagnostics.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Siemens Medical Solutions (Siemens) has been given the green light to acquire the diagnostics division of Bayer Healthcare (Bayer) without restrictions. The approval was granted by the...

Bio/Data Corp receives Health Canada licences.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Bio/Data Corp suburban Philadelphia-based developer, manufacturer and provider of haemostasis products, has received Class II medical device licences from Health Canada, and that Bio/Data...

The latest head-to-head clinical study comparing the risk of CIN between two contrast agents used in CE-MDCT examinations was published in investigative radiology.
October 31, 2006... (From Chemical Business NewsBase - Press Release) The results of a clinical study comparing Isovue-370 (iopamidol injection), marketed by Bracco Diagnostics Inc in the US, and Visipaque-320 (iodixanol injection), marketed by GE Healthcare...

Clinical Data announces licence agreements.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Clinical Data Inc has entered into an agreement with Mayo Foundation for Medical Education and Research (Mayo Clinic) granting Clinical Data Inc a licence under a variety of patents and...

MultiCell Technologies releases transcript of recent investor conference call discussing recent growth initiatives and growth of IP portfolio.
October 31, 2006... (From Chemical Business NewsBase - Press Release) MultiCell Technologies Inc (MultiCell) invites investors to review audio and written transcripts of a recent investor conference call in which Dr Stephen Chang, Chief Executive Officer of...

BioLife Solutions Inc and Corning Inc announce increased cell performance through product combination.
October 31, 2006... (From Chemical Business NewsBase - Press Release) BioLife Solutions Inc (BioLife) and Corning Inc announced the publication of a report that describes the benefits of the combination of the BioLife CryoStor CS5 with Corning's CellBIND...

Nymox pursuing plans for marketing partnerships for its NX-1207 BPH drug.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Nymox Pharmaceutical Corp (Nymox) is in discussions with potential marketing partners for the company's NX-1207 drug for the treatment of benign prostatic hyperplasia (BPH), following the...

Petroleum Consolidators announces Letter of Intent to acquire a major branded gas station.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Petroleum Consolidators of America Inc announced that it has formally entered into a Letter of Intent with an independent owner to acquire a BP branded gas station located in Charlotte...

Bristol-Myers Squibb, makers of Plavix, face injury lawsuits filed by Hersh & Hersh and Miller & Associates.
October 31, 2006... (From Chemical Business NewsBase - Press Release) The first personal injury lawsuit against the makers of Plavix, Bristol-Myers Squibb (BMS) and Sanofi-Aventis, has been filed by Hersh & Hersh and Miller & Associates. Among the...

IGI begins developing and manufacturing for SuperFoods Partners LLC.
October 31, 2006... (From Chemical Business NewsBase - Press Release) IGI Inc is developing and manufacturing skin care products containing special nutrient-based antioxidants combined with IGI's proprietary topical delivery technologies for SuperFoods...

Avanir receives FDA approvable letter for Zenvia for the treatment of involuntary emotional expression disorder.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Avanir Pharmaceuticals (Avanir) has received an approvable letter from the US Food and Drug Administration (FDA) for Zenvia for the treatment of involuntary emotional expression disorder...

CytRx's arimoclomol granted orphan drug designation in European Union for treatment of ALS.
October 31, 2006... (From Chemical Business NewsBase - Press Release) CytRx Corp announced that its lead drug candidate arimoclomol has been granted orphan medicinal product status for the treatment of amyotrophic lateral sclerosis (ALS) by the European...

Originally New York enters the renewable energy arena: ethanol plant construction and engineering.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Originally New York Inc (ONYI) has entered into the ethanol marketplace with the acquisition of ethanol industry assets, including real estate, heavy equipment, and a newly-renovated award...

NovaDel announces positive results from pilot study of Zolpidem oral spray vs Ambien tablets.
October 31, 2006... (From Chemical Business NewsBase - Press Release) NovaDel Pharma Inc announced positive results from a pilot pharmacokinetic study comparing its new and improved formulation of Zolpidem Oral Spray to Ambien tablets. Zolpidem is the active...

Pluristem expects to submit Pre-IND document to FDA by Dec 2006.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Pluristem Life Systems Inc (Pluristem) announced that it expects to submit the Pre-Investigational New Drug (Pre-IND) document describing the suggested clinical trial and the pre-clinical...

Teva announces global in-market 3Q 2006 Sales of Copaxone increased 15% to $354 M.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Teva Pharmaceutical Industries Ltd announced in conjunction with the release of the Sanofi-Aventis group's financial results, that global in-market sales of Copaxone in 3Q 2006 grew by 15%...

Usec, PPL sign new fuel supply contract.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Usec Inc has signed a long-term contract valued at more than $200 M with PPL Susquehanna LLC, to supply uranium enrichment for the company's Susquehanna nuclear power plant in Luzerne...

VWR International Inc opens a wholly owned subsidiary in India.
October 31, 2006... (From Chemical Business NewsBase - Press Release) VWR International Inc (VWR), a leader in the global research laboratory industry, announced the establishment of a full-service, wholly owned subsidiary in Bangalore, India to better serve...

GE Global Research receives major NHGRI research grant to enable faster, more cost-effective DNA sequencing.
October 31, 2006... (From Chemical Business NewsBase - Press Release) GE Global Research (GE), the centralized research organization of the General Electric Co, has received a $900,000 grant from National Human Genome Research Institute (NHGRI), part of the...

KV comments on recent lawsuit.
October 31, 2006... (From Chemical Business NewsBase - Press Release) KV Pharmaceutical Co (KV) reported that it recently had been served with a derivative lawsuit filed in St Louis City Circuit Court alleging that certain stock option grants to six current...

Bradley Pharmaceuticals announces Polyphenon E ointment, 15% approved by FDA.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Bradley Pharmaceuticals Inc (Bradley) announced that the company has been notified by MediGene AG that MediGene received FDA approval from the US Food and Drug Administration (FDA) to...

Ex-Im Bank facility supports Nigerian pharmaceutical production to combat sickle cell anaemia.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Companies in Florida, Georgia and Illinois are exporting equipment and services to a Nigerian pharmaceutical firm to help it in the fight against sickle cell anaemia. The exports by...

Memory Pharmaceuticals to receive $2 M milestone from Roche related to MEM 3454.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Memory Pharmaceuticals Corp announced that Roche has elected to maintain its option to obtain an exclusive license for MEM 3454, the lead compound from the companies' alliance focused on...

Watson receives FTC clearance for Andrx acquisition.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Watson Pharmaceuticals Inc (Watson) announced that the Federal Trade Commission (FTC) has accepted a proposed consent order for public comment relating to Watson's pending acquisition of...

BioMarin Pharmaceutical announces marketing approval for aldurazyme in Japan.
October 31, 2006... (From Chemical Business NewsBase - Press Release) BioMarin Pharmaceutical Inc announced that Japan's Ministry of Health, Labor, and Welfare has granted marketing authorization for Aldurazyme (laronidase), the first specific treatment...

AVI BioPharma discusses Phase II cardiovascular clinical study.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Clinicians involved in the performance of the APPRAISAL Phase II clinical study sponsored by AVI BioPharma Inc (AVI) and AVI's partner Cook Group Inc presented promising preliminary...

Medical Services International begins shipping VScan TB test kits to South Africa.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Medical Services International Inc has been requested to ship its VScan TB test kit to South Africa for testing. The company has already completed testing of its VScan Tuberculosis (TB)...

Array BioPharma's p38 inhibitor for inflammatory disease to advance into human clinical trials.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Array BioPharma Inc filed an Investigational New Drug (IND) application for ARRY-797 with the US Food & Drug Administration and is now able to proceed with human clinical studies. ARRY-797...

Bristol-Myers Squibb, makers of Plavix, face injury lawsuits.
October 31, 2006... (From Chemical Business NewsBase - Press Release) The first personal injury lawsuit against the makers of Plavix, Bristol-Myers Squibb and Sanofi-Aventis, has been filed. Among the allegations are misleading the public and hiding the...

Gene expression test from XDx now indicated for earlier use and prediction of acute cellular rejection.
October 31, 2006... (From Chemical Business NewsBase - Press Release) XDx announced expanded use and reimbursement for its first commercial offering, the AlloMap molecular expression test. Data from a recent study show that AlloMap testing, a non-invasive...

Shire announces study results for investigational drug (SPD465) designed to reduce ADHD symptoms for up to 16 hours.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Shire plc announced the results of two Phase II trials in adults (studies 201 and 203) of the investigational amphetamine compound SPD465 (triple-bead mixed amphetamine salts [MAS]) at a...

Bioject expands development agreement with leading European biotechnology company.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Bioject Medical Technologies Inc (Bioject) has expanded its agreement with an undisclosed European biotechnology company. The company entered into the next phase of development for a new...

Boehringer Ingelheim launches PROUD study to explore possible disease-modifying effect of pramipexole.
October 31, 2006... (From Chemical Business NewsBase - Press Release) A global clinical trial has been launched by Boehringer Ingelheim to assess the efficacy and safety of early pramipexole treatment versus delayed pramipexole treatment in patients with new...

Mirus Bio awarded broad European patent covering intravascular injection method.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Mirus Bio Corp announced the grant of European Patent EP1246649 entitled "Intravascular Delivery of Nucleic Acid." The patent broadly covers Pathway IV, a novel method to efficiently...

Pfizer updates preliminary results of torcetrapib/atorvastatin clinical trials as abstract for Phase III study is released.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Pfizer Inc provided an update on the preliminary results of its torcetrapib/atorvastatin clinical trials in connection with the release of an American Heart Association abstract of a Phase...

Jurak Corp announces extension to signed letter of intent.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Jurak Corp announced that, the Letter of Intent, announced on 26 Jul 2006, to acquire the worldwide marketing rights for the world's most powerful, natural immune booster discovered to...

Helm announces the formation of a pharmaceutical company focused on woman's health - Vibrel for woman introduced as new female intimate lubricant.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Helm Capital Group Inc (Helm) has successfully created a pharmaceutical company that is generating revenue. The company is in the early stages of marketing their first over-the-counter...

New report tackles safety concerns about Methadone for pain relief.
October 31, 2006... (From Chemical Business NewsBase - Press Release) A new report from Pain Treatment - Methadone Analgesia Safety Overview & Patient Instructions Handout - provides essential background information and serves as a gateway to several...

Genzyme launches new cystic fibrosis gene sequencing test.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Genzyme Corp announced the commercial availability of cystic fibrosis (CF) gene sequencing, a new diagnostic test that can detect about 98% of the more than 1200 disease-causing mutations...

Uroplasty receives FDA approval letter for Macroplastique.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Uroplasty Inc received from the US Food and Drug Administration (FDA) pre-market approval for its Macroplastique Implants. With this approval, Uroplasty can begin marketing Macroplastique...

Dividend declared by Albemarle.
October 31, 2006... (From Chemical Business NewsBase - Press Release) The board of directors of Albemarle Corp declared the quarterly dividend of 18 cts/share. The dividend is payable 1 Jan 2007 to shareholders of record 15 Dec 2006. The annualized dividend...

Atlanta-based Biofisica receives $5 M in Series A financing.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Biofisica Inc has closed on $5 M in Series A financing. The funds will be used to help launch POSiFECT RD Bio-Electric Stimulation Therapy, the first of its kind wound care product, in the...

Huntsman prices and increases size of private offering of senior subordinated notes.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Huntsman International LLC (Huntsman), a wholly owned subsidiary of Huntsman Corp, has priced its previously announced private offering of EUR and US dollar denominated senior subordinated...

Berlex Oncology evaluating combination therapy for common form of non-Hodgkin's lymphoma.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Berlex Oncology, a business unit of Berlex Laboratories, a US affiliate of Schering AG, Germany, announced that a clinical study in the US is underway investigating a new approach to...

Haber Inc updates progress on gold processing facility in US.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Haber Inc is preparing operations in its Massachusetts-based gold processing facility for a first run within the next two weeks from 31 Oct 2006. The company took possession of the...

Bionovo's Phase I/II clinical trial protocol for metastatic breast cancer accepted by FDA.
October 31, 2006... (From Chemical Business NewsBase - Press Release) The US Food and Drug Administration (FDA) has accepted Bionovo Inc's protocol to begin its multi-centre Phase I/II clinical trial for BZL101, the company's lead candidate for metastatic...

Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor Debio-025.
October 31, 2006... (From Chemical Business NewsBase - Press Release) The Debiopharm Group presented results from a Phase Ib study of cyclophilin inhibitor Debio-025, in treatment-naive HIV/HCV (hepatitis C virus) co-infected patients. The aim of the study...

Human Genome Sciences reports positive interim results of Phase II trials of Albuferon with ribavirin in patients with chronic hepatitis C.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Human Genome Sciences Inc reported the interim results of two Phase II clinical trials to evaluate the efficacy and safety of Albuferon (albumin- interferon alpha 2b) in combination with...

World IVD cardiac marker tests set to top $4.5 bn by 2010.
October 31, 2006... (From Chemical Business NewsBase - Press Release) With the global incidence of cardiovascular disease remaining the leading cause of morbidity and mortality, ferreting out the subtle indicators of impending incidence through in vitro...

Patient accrual completed into Phase III trial of Genasense in patients with acute myeloid leukaemia.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Genta Inc announced that target patient accrual has been completed into a randomised Phase III trial of Genasense plus chemotherapy in previously untreated patients with acute myeloid...

Canyon Copper acquires additional claims at the New York Canyon copper project.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Canyon Copper Corp announced that a further 322 mineral claims have been acquired by staking. These new claims are contiguous to the north of the claim group that forms the New York Canyon...

MacuSight initiates wet age-related macular degeneration study.
October 31, 2006... (From Chemical Business NewsBase - Press Release) MacuSight Inc announced the initiation of a Phase I study of its lead product candidate in patients with wet age-related macular degeneration (wet AMD). This trial, which will enroll a...

Biomira announces acquisition of ProlX Pharmaceuticals.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Biomira Inc has acquired ProlX Pharmaceuticals Corp (ProlX) of Tucson, AZ, and Houston, TX, a privately-held biopharmaceutical company focused on the development of novel therapeutics for...

Portola advances ADP programme: initiates Phase I trial with IV formulation, trials with oral formulation ongoing.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Portola Pharmaceuticals Inc (Portola) has initiated a Phase I clinical trial in healthy volunteers with the intravenous (IV) formulation of its ADP receptor antagonist, an antiplatelet...

Advancis Pharmaceutical submits proposed order in corporate name infringement lawsuit.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Advancis Pharmaceutical Corp (Advancis) has jointly submitted with sanofi-aventis a proposed Permanent Injunction and Order to the US District Court for the District of Delaware, pursuant...

Vical acquires angiogenesis and poloxamer patents from Valentis.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Vical Inc has acquired from Valentis Inc certain pending patents that complement the company's existing intellectual property positions in poloxamers and angiogenesis, and licensed from...

Dunlop puts muscle behind new Direzza Sport Z1 extreme tyre.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Dunlop Tires (Dunlop) introduced an extreme sports performance tyre with race-like characteristics for drifting, on-track and autocross motorsports. The street-legal Direzza Sport Z1 is...

CDC to evaluate Novavax's pandemic influenza vaccine candidate.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Novavax Inc said the US Centres for Disease Control and Prevention (CDC) has agreed to evaluate the company's H5N1 pandemic influenza vaccine candidate, including pre-clinical testing of...

Royal Dutch Shell plc: Buyback of own shares.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Royal Dutch Shell plc announces that on 31 Oct 2006 it purchased for cancellation 400,000 A Shares at a price of EUR 27.31/share. It further announces that on the same date it purchased...

Introgen Therapeutics and Gendux AB announce agreement with European Medicines Agency to file for Advexin approval under exceptional circumstance rules.
October 31, 2006... (From Chemical Business NewsBase - Press Release) Gendux AB and Introgen Therapeutics Inc (Introgen) have reached agreement with the European Medicines Agency (EMEA) Committee to file for Advexin p53 therapy marketing approval under the...

EpiCept regains North American rights to LidoPAIN SP.
October 31, 2006... (From Chemical Business NewsBase - Press Release) EpiCept Corp announced that the North American rights for LidoPAIN SP, EpiCept's sterile prescription analgesic patch designed to provide sustained topical delivery of lidocaine to a...